-
Modeling the Path to Cure: How (NEO)Adjuvant Drug Therapies are Evaluated in Health Technology Assessment (HTA)
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Protocol Biopsy and Non-Invasive Biomarkers for Monitoring Transplant Rejection Within One-Year Post-Kidney Transplants
Mar 10, 2025, 14:00 PM -
Indication Screening: Using Early Health Technology Assessment to Prioritize Potential Target Indications for Platform Health Technologies
Mar 10, 2025, 14:00 PM -
Estimating the HRQoL Shortfall of Long COVID: Meta Analysis of Cohort Studies Relative to Population Norms
Mar 10, 2025, 14:00 PM -
The Potential Clinical Impact of the Moderna Next-Generation COVID-19 mRNA-1283 Vaccine in United States (US) Adults
Mar 10, 2025, 14:00 PM -
Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy
Mar 10, 2025, 14:00 PM -
Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan
Mar 10, 2025, 14:00 PM -
Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study
Mar 10, 2025, 14:00 PM -
Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis
Mar 10, 2025, 14:00 PM -
Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs
Mar 10, 2025, 14:00 PM -
Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors
Mar 10, 2025, 14:00 PM -
Enhancing Patient Engagement in Pharmacist-Provided Medication Therapy Management for Chronic Conditions
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness (CEA) of Etonogestrel Subdermal Implant in a Brazilian Private Health Insurance
Mar 10, 2025, 14:00 PM -
Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)
Mar 10, 2025, 14:00 PM -
Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China
Mar 10, 2025, 14:00 PM -
K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)
Mar 10, 2025, 14:00 PM -
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fractures In Neurologically Intact Patients: A Cost-Utility Analysis
Mar 10, 2025, 14:00 PM -
Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024
Mar 10, 2025, 14:00 PM